Peptide Sciences Review 2026: Shutdown, Testing, & Alternatives
Shop Our Top Compounds
Research-use-only notice: This article discusses suppliers of materials intended solely for legitimate in-vitro laboratory research. It is not medical advice and does not describe products for human or animal use. Researchers remain responsible for verifying identity, documentation, handling requirements, and institutional compliance before placing an order.
Quick Answer
Peptide Sciences is closed. In early March 2026, commonly reported as March 6, the company replaced its storefront with a notice saying it had voluntarily shut down operations and discontinued sales of its research products. Its website may still be reachable, but it is not an active storefront. The company has not publicly given a reason for the closure.
That distinction matters because the Peptide Sciences name has long had recognition among research-peptide buyers. A live domain, an old product page, or a social-media account should not be interpreted as proof that a seller is authorized. Peptide Sciences expressly cautioned that any website, platform, entity, or individual claiming affiliation with it is unauthorized and fraudulent. For researchers who previously relied on its catalog, the practical next step is to evaluate active vendors afresh: verify the current operator, review lot-specific analytical material, compare the exact format and quantity needed, and use a payment and shipping process appropriate to institutional purchasing.
IronPeak Peptides is one active U.S.-based option for researchers seeking a documented catalog. It fulfills from Iowa, lists more than 70 products, and provides lot-specific documentation with every order. It is not, however, a one-for-one continuation of Peptide Sciencesβ former catalog; product availability, formats, pricing, and documentation practices should be compared item by item.
Peptide Sciences at a Glance
| Category | Current assessment |
|---|---|
| Operating status | Closed; voluntary shutdown announced in early March 2026. The former site displays a closure notice rather than an active store. |
| Catalog size | Historically broad, spanning multiple research-peptide and adjacent product categories. |
| Regulatory record | No direct FDA enforcement document or confirmed warning letter to Peptide Sciences was identified in this review. FDA briefing materials that cited product pages were not enforcement actions. |
| Independent testing | Finnrick reports 132 tests: 79 pass and 53 fail, for a 61% overall rating and rank 262 of 307. Post-closure sample provenance is an important limitation. |
| Documentation | Historical product information and analytical materials should not be treated as current or sufficient for a new purchase. Researchers should seek lot-specific records from an active supplier. |
| What researchers should know | Do not treat apparent successor sites as authorized. Confirm the sellerβs identity, current catalog, shipping policies, and documentation before ordering. |
Company Overview
Peptide Sciences was a Henderson, Nevada-based seller that had been operating by at least the early-to-mid 2010s. Over time, it became a familiar name in the U.S. research-peptide market, in part because of its broad selection and a relatively polished retail presentation. Its historical catalog included tissue-research products, growth-hormone secretagogues, GLP-related materials, growth factors, pigmentation-focused compounds, cosmetic peptides, capsules, and topicals. That assortment gave laboratories and independent researchers a single place to compare a wide range of research materials and ancillary items.
The companyβs positioning was generally more premium than a bare-bones marketplace. Historical discussions often described a straightforward ordering flow, domestic fulfillment, protective packaging, and a selection that was deeper than many small specialty sellers. Those attributes help explain why its closure attracted attention: a large catalog can reduce procurement friction, especially when a research program is comparing multiple materials or formats.
Still, catalog breadth and reputation are not substitutes for present-tense verification. A supplier assessment should separate what a company historically offered from what can be documented for the particular lot in front of a researcher. This is particularly important after a closure, when old pages, archived certificates, search snippets, and third-party listings can persist long after commerce has ended.
What Happened: The Shutdown
Peptide Sciences announced a voluntary shutdown in early March 2026. Its statement reads: βAfter careful consideration, Peptide Sciences has decided to voluntarily shut down operations and discontinue the sale of its research products.β The notice did not provide a stated reason, timetable beyond the closure, or a designated successor.
The company also issued an unusually direct warning about affiliation claims: βAny website, platform, entity, or individual claiming affiliation with Peptide Sciences… is unauthorized, fraudulent, and has no affiliation with our company.β That warning should be read literally. A seller using a similar name, former product images, inherited-looking copy, or claims of access to old inventory has not thereby established a relationship with the former company.
There is broader industry uncertainty around research materials, changing supplier practices, payment processing, and online retail compliance. However, no public explanation from Peptide Sciences ties its shutdown to any one factor. It would therefore be inappropriate to present industry context as a confirmed cause. The evidence supports a narrower conclusion: the company chose to discontinue operations, and the reason was not stated.
For existing customers, the operational consequence is simple. Historical orders, product descriptions, and supplier accounts may be useful records, but they are not a route to new authorized purchases. Researchers should retain their own order and lot records according to laboratory policy, then begin vendor qualification from the current market rather than assume continuity.
Independent Testing Record
Third-party testing databases can add an external data point, but their value depends on sample chain of custody, test method, reporting transparency, and whether the tested item can confidently be connected to the original seller. Finnrickβs aggregate record for Peptide Sciences reports 132 total tests, with 79 passes and 53 failures. It assigns a 61% overall rating and ranks the company 262 out of 307 sellers in its system.
The database lists testing across ten products: GHK-Cu, semaglutide, PT-141, ipamorelin, tirzepatide, BPC-157, IPP-3 RT, Melanotan II, tesamorelin, and CJC-1295. Its product-level figures were uneven. Finnrick reports 13 BPC-157 tests and a 60% rating, citing results below 99.5% purity and under-filled vials. For IPP-3 RT, it reports 41 tests and a 56% rating, including identity failures and over-fills. Tirzepatide is shown at 17 tests and 68%, while semaglutide is shown at 15 tests and 81%.
The lowest reported result among the listed products was CJC-1295: 11 tests and a 17% rating. These figures are meaningful as a caution against relying on brand recognition alone. At the same time, they should not be overstated. A database aggregate is not a complete audit of every lot ever shipped, and a nominal βpassβ or βfailβ does not independently reveal all analytical parameters, sampling procedures, or storage history.
There is an additional, material caveat here: samples reported after the closure may have been obtained from a lookalike or otherwise unauthorized seller rather than from the original Peptide Sciences operation. The former companyβs own fraud warning makes that possibility especially relevant. The most defensible reading is that Finnrickβs record identifies variability associated with samples represented as Peptide Sciences products, while provenance uncertainty limits conclusions about the original companyβs final inventory. Researchers should request current, lot-matched records directly from whichever active supplier they are evaluating.
Historical Catalog and Pricing
Peptide Sciencesβ former catalog was wide enough to appeal to researchers looking across several categories rather than for a single material. In addition to its peptide lines, it carried capsules, topicals, and cosmetic-oriented products. Historical price points illustrate its higher-priced positioning: BPC-157 5 mg was listed at $59.50, TB-500 5 mg at $85, and GHK-Cu 200 mg at $200. Across the broader historical catalog, listed prices ranged roughly from $24 to $600 depending on the item and format.
Price comparisons require careful normalization. The vial quantity, presentation, analytical documentation, shipping threshold, and date of the listing can change the apparent bargain. A 5 mg historical listing should not be compared as if it were interchangeable with a current 10 mg listing, and an archived price does not indicate that an item remains purchasable.
For a current reference point, IronPeak lists BPC-157 10 mg at $55. Its catalog also includes semaglutide as IPP-1 SM in a 5 mg format and tirzepatide as IPP-2 TRZ in a 10 mg format. IronPeak lists Hospira BAC Water, 30 mL, at $14.99. These are current catalog comparisons, not claims that every former Peptide Sciences item has an IronPeak equivalent. Researchers should compare the exact research material, amount, lot documentation, and ordering terms before deciding which option fits a protocol or purchasing process.
Historically, Peptide Sciences advertised U.S.-based fulfillment with one to two business days of processing and estimated U.S. delivery in two to five days. Reports described a $15 flat shipping charge and free shipping above $200. IronPeakβs current terms are standard shipping at $14.99, complimentary shipping at $300 or more, and Priority shipping at $29.99. These policies are operational details, not quality indicators, but they can materially affect a labβs purchasing plan and order consolidation.
Customer Reviews and Community Sentiment
Public feedback on Peptide Sciences was mixed, and the source quality varies. Reviews.io displays a 2.1 out of 5 score from 17 reviews, with 29% of reviewers recommending the company. That is a small sample, so it should not be treated as a statistical portrait of all historical customers. It does nonetheless provide a visible counterweight to the brandβs long-standing name recognition.
Reddit discussions were historically more favorable in tone, particularly around shipping speed, packaging, catalog selection, and the convenience of domestic fulfillment. At the same time, commenters regularly described premium pricing and variable perceived results. Anecdotes of this kind are useful for identifying themes worth investigatingβsuch as fulfillment consistency or price positioningβbut they do not establish identity, purity, fill quantity, or suitability for laboratory work. They are also especially vulnerable to manipulation, selection bias, and changes in ownership or sourcing.
There is no confirmed Trustpilot profile for the original company, and a Better Business Bureau profile sometimes associated with the name is not for the original Peptide Sciences business. Researchers should be wary of review aggregations that blend similarly named businesses, unverified storefronts, or successor claims. The closure makes attribution harder, not easier.
The balanced takeaway is that Peptide Sciences had genuine historical visibility and strengths that some customers valued, but the available review evidence was neither uniformly positive nor strong enough to replace documentation. Its current closed status should dominate any purchasing decision: customer-service memories cannot establish that a present-day seller is legitimate.
Quality Documentation Checklist
When qualifying any active research-material supplier, the central question is not whether a brand has a recognizable name. It is whether the seller can connect the exact item being offered to usable, lot-specific evidence. A practical review should begin with a quality assurance documentation or equivalent analytical documentation that identifies the product, lot or batch, date, method, and reported result. The document should be legible, internally consistent, and supplied for the item actually being ordered rather than as a generic marketing attachment.
Researchers should also ask what the reported test does and does not establish. Identity, purity, quantity, residual solvents, microbial considerations, and stability are different questions that may require different methods or records. A chromatogram without clear sample identification, an undated generic PDF, or an unexplained batch number should prompt follow-up rather than confidence. Storage and transport guidance, container information, and a clear point of contact are also relevant to reproducibility and recordkeeping.
Peptide Sciences historically made product information and analytical materials available in connection with its catalog, but historical pages cannot be independently treated as current documentation for a new order now that the company is closed. An old certificate proves, at most, what the document purports to describe; it does not validate inventory offered by an unaffiliated seller. This is one reason the closure noticeβs warning about claimed affiliations matters.
IronPeakβs current approach is to include lot-specific documentation with every order. That provides a clearer starting point for matching receipt, product, and record in a laboratory file. It does not eliminate the researcherβs need to review the documentation or validate it against the needs of the work. The appropriate standard is evidence tied to the delivered lot, not a general assertion of quality or a historical brand reputation.
IronPeak as an Alternative
IronPeak may fit researchers who want an active U.S.-based supplier, Iowa fulfillment, a catalog of more than 70 products, and lot-specific documentation with each order. Its catalog includes BPC-157 10 mg, IPP-1 SM, IPP-2 TRZ, and ancillary laboratory supplies such as Hospira BAC Water. Its published shipping optionsβ$14.99 standard shipping, free shipping at $300 or more, and $29.99 Priorityβmay also suit researchers consolidating documented purchases.
It may not fit every former Peptide Sciences customer. The former companyβs catalog was unusually broad, and no responsible alternative should imply universal product parity without comparing the exact listing. Researchers who need a particular historical format, a topically presented item, a specialty material, a certain quantity, or a different fulfillment arrangement should confirm availability before changing suppliers. Likewise, a lower headline price alone should not decide the question; the comparison should include quantity, documentation, shipping, and the research programβs own acceptance criteria.
In other words, IronPeak is best viewed as a current, documented option to evaluateβnot as an automatic successor to a closed company. That framing respects both the discontinuity created by the shutdown and the need for a defensible procurement record.
Final Verdict
Peptide Sciences was a significant historical participant in the research-peptide market. Its broad catalog, domestic fulfillment, and recognizable brand gave it a meaningful following, while its premium pricing, mixed public reviews, and uneven third-party testing record supplied important reasons for caution. Finnrickβs 61% aggregate rating and product-level variability are relevant data points, but they must be read alongside limitations in sample provenance, especially after the closure.
The decisive fact in 2026 is that Peptide Sciences is no longer operating. It voluntarily discontinued sales and warned that purported affiliates are unauthorized and fraudulent. Researchers should not use a surviving website, a copied listing, or a historical certificate as evidence that an apparent successor is legitimate. The better approach is to assess active vendors from first principles: lot-matched documentation, clear seller identity, transparent terms, appropriate shipping, and a catalog that actually matches the materials required for legitimate in-vitro research. IronPeak is one active option that can be evaluated on those current criteria.
Frequently Asked Questions
Is Peptide Sciences still operating?
No. Peptide Sciences announced a voluntary shutdown in early March 2026 and discontinued sales of its research products. Its website may remain online, but it is not an active storefront.
What happened to Peptide Sciences?
The company said it voluntarily decided to shut down operations after careful consideration. It did not state a public reason. It also warned that parties claiming affiliation with Peptide Sciences are unauthorized and fraudulent.
Are Peptide Sciences successor sites or affiliates legitimate?
The companyβs closure notice says that websites, platforms, entities, and individuals claiming affiliation are unauthorized and fraudulent. Do not infer authorization from a similar name, familiar product photos, or legacy-looking web copy.
Where can researchers source materials now?
Researchers should evaluate active suppliers based on the exact materials needed, seller identity, current lot-specific documentation, shipping terms, and institutional purchasing requirements. IronPeak is a U.S.-based option with more than 70 products and lot-specific documentation with every order, but it is not a guaranteed match for every former Peptide Sciences listing.
How did Peptide Sciencesβ independent testing compare?
Finnrick reports 132 tests associated with Peptide Sciences, with 79 passes and 53 failures, producing a 61% rating. Results varied substantially by product, including a reported 17% rating across 11 CJC-1295 tests. Because post-closure samples may originate from an unauthorized lookalike seller, those data should be interpreted with provenance caution.
Was Peptide Sciences subject to an FDA warning letter?
This review found no direct FDA enforcement document or confirmed warning letter addressed to Peptide Sciences. FDA briefing documents cited some product pages as examples of online listings, including ipamorelin in October 2024, CJC-1295 in December 2024, and KPV and Epitalon in July 2026; those references were not enforcement actions. Claims of a 2023 FDA warning letter could not be substantiated.
Research Availability by State
IronPeak Peptides delivers research-grade compounds to laboratories and institutions across the United States. Browse peptide availability in Indiana, Mississippi, North Dakota, Utah, Arkansas, and all 50 states.
🔬 Explore Research Peptides
- Glow BPC-70 70mg — $99.00
- SLU-PP-332 — $249.00
- TB-500 10mg — $69.99
- CJC-1295 with DAC 5mg — $55.00
